Chia‐Feng Tsai

Oregon Health & Science University — United States

Physics and Astronomy · Physical Sciences

30h-index4.2kcitations1.3kworks0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ionosphere and magnetosphere dynamics(1185), Geophysics and Gravity Measurements(1185), Solar and Space Plasma Dynamics(795), Methane Hydrates and Related Phenomena(272), Earthquake Detection and Analysis(118)

Publications1.3k total

Mutant ASXL1 Drives Transcriptional Activation and Repression in Human Hematopoiesis
2026
MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia
2026Open Access
Supplementary Figures from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis
Nature Communications·2025· 4 citedOpen Access
Supplementary Methods1 from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models
2025Open Access
Supplementary Tables1 from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models
2025Open Access
Data from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models
2025Open Access
Supplementary Figures1 from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models
2025Open Access
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models
Clinical Cancer Research·2025· 3 citedOpen Access
Abstract 1967: Plexin-B2 mediates tumor cell clustering with monocyte interactions in breast cancer metastasis
Cancer Research·2025
Abstract 4292: Targeting YB-1 as a treatment strategy for high-grade serous ovarian carcinoma
Cancer Research·2025
Long-read RNA sequencing atlas of human microglia isoforms elucidates disease-associated genetic regulation of splicing
Nature Genetics·2025· 15 cited
Robust collection and processing for label-free single voxel proteomics
Nature Communications·2025· 9 citedOpen Access
Supplementary Figures from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
page 1 of 67Next →

Frequent Co-authors

Tao Liu(22), Richard Smith(21), Ronald Moore(18), Tujin Shi(17), Karin Rodland(14), Marina Gritsenko(12), Yu‐Ju Chen(12), Ying Zhu(10), Yi‐Ting Wang(9), Vladislav Petyuk(8), Rui Zhao(8), William Chrisler(8), Rosalie Chu(7), Karl Weitz(7), Matthew Monroe(7), Matthew A. Wyczalkowski(7), Li Ding(7), Athena Schepmoes(7), Ana I. Robles(6), Mathangi Thiagarajan(6)